{"url_path":"/sec/kapa/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-022796-index.html","accession_number":"0001493152-26-022796","cik":"0001962011","ticker":"KAPA","issuer_name":"Kairos Pharma, LTD.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-022796-index.html","primary_entity_key":"0001962011","primary_entity_name":"Kairos Pharma, LTD."},"word_count":84,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nWe\nare not presently party to any pending or other threatened legal proceedings or claims that we believe will have a material adverse effect\non our business, financial condition or operating results, although from time to time, we may become involved in legal proceedings in\nthe ordinary course of business. We maintain insurance policies in amounts and with the coverage and deductibles we believe are adequate,\nbased on the nature and risks of our business, historical experience and industry standards."}